AlgiPharma AS
PrivateLast Round
Grant
Dec 20, 2021
Total Funding Raised
$23.57M
Company Overview
AlgiPharma AS is a biopharmaceutical company that develops proprietary alginate technology for drug delivery platforms, drug conjugates, and therapeutic applications in areas such as cystic fibrosis, COPD, and infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AlgiPharma AS Comparables
Compare AlgiPharma AS with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Renovion, Inc. | 82% | |
| Enterprise Therapeutics | 80% | |
| Aer Therapeutics | 77% |
AlgiPharma AS Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 20, 2021 | ||||
| Grant | Jan 15, 2018 | ||||
| Grant | Jan 15, 2018 | ||||
| Grant | Jan 15, 2018 | ||||
| Grant | Jan 15, 2018 | ||||
Grant | Jun 3, 2016 |
AlgiPharma AS Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovasjon Norge | Grant |
| European Union's Horizon 2020 | Grant |
| Cystic Fibrosis Foundation | Grant |
| Innovate UK | Grant |
| The Research Council of Norway | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 6, 2026
Monthly visitors increased 226% MoM, reaching 2.7K.
- Jun 1, 2025
Monthly visitors increased 912% MoM, reaching 1.7K.
AlgiPharma AS Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about AlgiPharma AS's valuation, stock price, and market status.
Is AlgiPharma AS a public or private company?
AlgiPharma AS is a private company.
What is the current stock price of AlgiPharma AS?
AlgiPharma AS is a private company with no public stock price. No recent secondary market data is available.
How much is AlgiPharma AS worth (valuation)?
Valuation information for AlgiPharma AS is not publicly available.
Can I buy AlgiPharma AS stock?
AlgiPharma AS shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was AlgiPharma AS's last funding round?
AlgiPharma AS's most recent funding round was Grant on December 20, 2021.
Who are the main investors in AlgiPharma AS?
Key investors in AlgiPharma AS include Innovasjon Norge, Cystic Fibrosis Foundation, Innovate UK, The Research Council of Norway, European Union's Horizon 2020 programme.
Will AlgiPharma AS IPO soon?
No public IPO plans have been announced for AlgiPharma AS.
How can I track AlgiPharma AS secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AlgiPharma AS's secondary market activity and sign up for updates.